BackMeridian Bioscience Overview

Meridian Bioscience Receivables

Track Meridian Bioscience's receivables ($42M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$41.57M
↓ 6.16% YoYΔ $-2.73M vs prior year quarter

Peer average

Loading

Meridian Bioscience Receivables History

Loading

Meridian Bioscience vs. peers: Receivables Comparison

Loading

Meridian Bioscience Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Meridian Bioscience (VIVO) FAQ

As of the most recent data (December 2022), VIVO shows a receivables of $42M. That compares with $44M in the prior-year period — down 6.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VIVO's receivables is now $42M (was $44M) — a 6.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Meridian Bioscience is outperforming or lagging.

Tracking VIVO's receivables over time shows whether Meridian Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $42M That compares with $44M in the prior-year period — down 6.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Meridian Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $42M) with ownership activity and broader fundamentals.

Meridian Bioscience's receivables is $42M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.